GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) » Definitions » 3-Year Book Growth Rate

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) 3-Year Book Growth Rate : -2.90% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Suzhou Zelgen Biopharmaceuticals Co 3-Year Book Growth Rate?

Suzhou Zelgen Biopharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥6.02.

During the past 12 months, Suzhou Zelgen Biopharmaceuticals Co's average Book Value per Share Growth Rate was 124.60% per year. During the past 3 years, the average Book Value per Share Growth Rate was -2.90% per year. During the past 5 years, the average Book Value per Share Growth Rate was 92.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 8 years, the highest 3-Year average Book Value per Share Growth Rate of Suzhou Zelgen Biopharmaceuticals Co was 450.10% per year. The lowest was -2.90% per year. And the median was 58.30% per year.


Competitive Comparison of Suzhou Zelgen Biopharmaceuticals Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, Suzhou Zelgen Biopharmaceuticals Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Zelgen Biopharmaceuticals Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Zelgen Biopharmaceuticals Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Suzhou Zelgen Biopharmaceuticals Co's 3-Year Book Growth Rate falls into.



Suzhou Zelgen Biopharmaceuticals Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Suzhou Zelgen Biopharmaceuticals Co  (SHSE:688266) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Suzhou Zelgen Biopharmaceuticals Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Suzhou Zelgen Biopharmaceuticals Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Business Description

Traded in Other Exchanges
N/A
Address
No.209 Chenfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN
Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.
Executives
Zhang Bin Core technical personnel
Huang Gang senior management
Lv Bin Hua Directors, senior managers, core technical personn
Lu Hui Ping Directors, senior managers
Gao Qing Ping senior management
Wu Ji Sheng Directors, senior managers, core technical personn
Zhang Jun Li senior management
Wu Li Qing Core technical personnel
Core technical personnel
Sheng Ze Lin Directors, senior managers, core technical personn

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Headlines

No Headlines